Abstract:
Medicinal plants have been used in centuries as a remedy for human diseases
because they contain components of therapeutic value. The development of drug
resistance to available antibiotics has also led to investigation of antimicrobial
alternatives from medicinal plants. The Acquired Immunodeficiency Syndrome
(AIDS) caused by the Human Immunodeficiency Virus (HIV) is an important public
health problem in sub – Sahara Africa. Currently the treatment of the disease is
mainly directed at secondary microbial infections mainly bacterial and fungal that
account for up to 70% of HIV/AIDS defining illness.
From literature search by online sources, databases and search engines, a number of
plants used in traditional health systems in Kenya were selected for study, of which
basing on ethno botanical application and accessibility to their natural habitats three;
Aspilia mossambicensis (Oliv.) Wild, Ocimum gratissimum (L.) Labiatae. and
Toddalia asiatica (L.) Lam. (Rutaceae) were investigated with an overall aim of
identifying and evaluating the bioactive antimicrobial agents.
Sequential extraction with organic solvents (n-Hexane, ethyl acetate and methanol)
realized percentage yields in the range 0.5% (Ocimum gratissimum stem bark ethyl
acetate extract) to 2.7% (Toddalia asiatica root bark methanol extract). Steam
distillation enabled extraction of volatile oils with highest yields being 0.45%
(Ocimum gratissimum leaves).
Antibacterial and antifungal assays were done on the crude extracts and volatile oils
derived from these plants by disc diffusion susceptibility testing method. The highest
activity was with Toddalia asiatica stem bark methanol extract (15mm diameter
xvii
zone of inhibition) against Methicillin Resistant Staphylococcus aureus for
antibacterial assays and the ethyl acetate extract (22mm diameter zone of inhibition)
against Microsporum gypseum for antifungal assays. Ocimum gratissimum leaves’
volatile oils elicited activity across all the fungal strains tested against in the range of
12mm to 22mm inhibition zone diameter, this was a confirmation of explosive
studies carried out previously hence no basis for further analysis. Statistical data
analysis of the bioassays data using the Statistics Package for Social Scientists
(SPSS) illustrated significance in the variation of bioactivity; from plant to plant,
among different plant parts and for different extracts as expressed by F – statistics.
Bioactivity-guided fractionation of the Toddalia asiatica (stem bark methanol
extract) yielded Methyl (6-methoxy-2-oxo-2H- chromen- 7 –yl) acetate (F4-C) (6),
which was characterized using Ultra Violet, Infra Red, Nuclear Magnetic Resonance
and Mass Spectroscopy and comparison with spectra of authentic samples. By
bioautographic selection (F4-C) (6), showed antimicrobial activity against
Methicillin Resistant Staphylococcus aureus (10mg/ml) and Cryptococcus
neoformans (5mg/ml). F’9-I’ (structure elucidation to be summed up) elicited
antibacterial activity against Pseudomonas aeruginosa (10mg/ml).
These results validate the ethno botanical use of Toddalia asiatica a Kenyan
medicinal plants for conditions that may be of bacterial and fungal etiology.